Pisco João, Bilhim Tiago, Pinheiro Luis C, Fernandes Lúcia, Pereira José, Costa Nuno V, Duarte Marisa, Oliveira António G
Interventional Radiology Department, Hospital Saint Louis, R. Luz Soriano, Lisbon 1200-249, Portugal.
Interventional Radiology Department, Hospital Saint Louis, R. Luz Soriano, Lisbon 1200-249, Portugal; Radiology Department, Medicine Faculty, Universidade Nova de Lisboa, Lisbon, Portugal.
J Vasc Interv Radiol. 2016 May;27(5):700-8. doi: 10.1016/j.jvir.2016.01.138. Epub 2016 Mar 26.
To evaluate efficacy of prostate artery embolization (PAE) in patients with benign prostatic hyperplasia (BPH), prostate volume (PV) > 100 cm(3).
This was a single-center retrospective cohort study. Between March 2009 and September 2014, PAE was performed in patients with a diagnosis of BPH, PV > 100 cm(3), and moderate to severe lower urinary tract symptoms (LUTS) refractory to medical treatment for at least 6 months or who had acute urinary retention. Success was defined as improved symptoms (International Prostate Symptom Score ≤ 15 and decrease of ≥ 25% from baseline score), improved quality of life (measured as score of ≤ 3 points or decrease of ≥ 1 point from baseline), and no need for additional treatment.
PAE was performed in 152 patients 48-87 years old (mean ± SD 67.4 y ± 7.5) with mean PV of 134.2 cm(3) ± 41.8 (range, 101-383 cm(3)). PAE was technically successful in 149 patients (98.0%). Symptomatic control was achieved for a median of 18 months ± 15.5 (range, 3-66 mo). There were 33 clinical failures (23.6%); 23 occurred in the short-term (≤ 6 mo), and 10 occurred in the medium-term (6-24 mo); there were no long-term failures (> 36 mo). Cumulative clinical success rates were 90%, 87.9%, 83.5%, 81.1%, and 77.8% at 1, 3, 6, 12, and 18 months and 72.4% thereafter to 66 months (5.5 y).
PAE provides sustained short-, medium-, and long-term control for LUTS in patients with BPH and PV > 100 cm(3).
评估前列腺动脉栓塞术(PAE)对前列腺体积(PV)>100 cm³的良性前列腺增生(BPH)患者的疗效。
这是一项单中心回顾性队列研究。2009年3月至2014年9月期间,对诊断为BPH、PV>100 cm³且有中度至重度下尿路症状(LUTS)且药物治疗至少6个月无效或有急性尿潴留的患者进行PAE。成功定义为症状改善(国际前列腺症状评分≤15分且较基线评分降低≥25%)、生活质量改善(测量为评分≤3分或较基线降低≥1分)且无需额外治疗。
对152例年龄在48 - 87岁(平均±标准差67.4岁±7.5)的患者进行了PAE,平均PV为134.2 cm³±41.8(范围101 - 383 cm³)。149例患者(98.0%)PAE技术成功。症状控制的中位时间为18个月±15.5(范围3 - 66个月)。有33例临床失败(23.6%);23例发生在短期(≤️6个月),10例发生在中期(6 - 24个月);无长期失败(>36个月)。1、3、6、12和18个月时的累积临床成功率分别为90%、87.9%、83.5%、81.1%和77.8%,此后至66个月(5.5年)为72.4%。
PAE可为PV>100 cm³的BPH患者的LUTS提供持续的短期、中期和长期控制。